Edward Ludwig
Non-Executive Chairman of the Board of Directors @ POCARED Diagnostics
Demarest, United States
Edward Ludwig is a seed investor at POCARED Diagnostics in Demarest focused on Medical and Health Care. Edward Ludwig has been a Member of the Board of Directors of Boston Scientific since March 2014. Edward is the former Chairman of the Board of Directors of Becton, Dickinson and Company (“BDX”), a global medical technology company, having served in that position from February 2002 through June 2012. Edward also served as BDX’s ChiefExecutive Officer from January 2000 to September 2011 and as its President from May 1999 to December 2008. Edward joined BDX as a Senior Financial Analyst in 1979. Prior to joining BDX, Edward served as a Senior Auditor with Coopers and Lybrand (now PricewaterhouseCoopers) where he earned his CPA and as a financial and strategic analyst at Kidde, Inc. Edward serves as Lead Director on Aetna Inc.’s Board of Directors and chairs its Finance Committee and is a Member of the Board of Directors of Xylem, Inc. Edward serves as the Non-Executive Chairman of POCARED, a privately held firm in Israel. Edward is also a Member of the Board of The Center for Higher Ambition Leadership, which is dedicated to studying, documenting and advancing the principals of Higher Ambition Leadership that drive the most successful enterprises in terms of longer term shared value creation. Edward served as a Member of the Board of Trustees of the College of the Holy Cross (2005-2013), and the Columbia Business School Board of Overseers (2010-2015). Edward also served as a Member of the Board of Trustees of the Hackensack University Medical Center Network Board of Trustees. Edward received a B.A. degree in Economics and Accounting from The College of the Holy Cross and a MBA degree from Columbia University.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Edward Ludwig invests in
Stages Edward Ludwig invests in
Countries Edward Ludwig invests in
Investment Focus
Industry
- Medical 2 (50%)
- Health Care 1 (25%)
- Biotechnology 1 (25%)
- Medical Device 1 (25%)
- Consumer Electronics 1 (25%)
Stage
- Seed 2 (50%)
- Series A 1 (25%)
- Corporate Round 1 (25%)
Country
- Switzerland 1 (25%)
- United States 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
LIOM
|
LIOM is a Swiss deep-tech company building the ultimate health wearable for conscious living – a continuous, needle-free window into your body's chemistry, starting with glucose. Through this, we empower users to make informed lifestyle choices and live healthier and longer lives. Developed in Switzerland over 8+ years by 50+ scientists,validated across 130+ subjects, and protected by 23 patent families. | $18M / Seed / Apr 29, 2021 | |
Velano Vascular
|
Velano Vascular is a medical device innovator committed to reducing the pain, risk and inefficiencies of traditional blood collection practices while enhancing the clinical domain of vascular access. The company’s revolutionary FDA-approved PIVO device expands the use of peripheral IV lines for frequent, high quality blood draws, aiming to deliverpainless, compassionate care for hospital inpatients, a safer practice for caregivers, and a more financially responsible alternative for health systems. More information is available at www.velanovascular.com. | $10M / Corporate Round / May 08, 2019 | |
|
Velano Vascular
|
Velano Vascular is a medical device innovator committed to reducing the pain, risk and inefficiencies of traditional blood collection practices while enhancing the clinical domain of vascular access. The company’s revolutionary FDA-approved PIVO device expands the use of peripheral IV lines for frequent, high quality blood draws, aiming to deliverpainless, compassionate care for hospital inpatients, a safer practice for caregivers, and a more financially responsible alternative for health systems. More information is available at www.velanovascular.com. | $3.5M / Series A / Feb 08, 2016 | |
|
LIOM
|
Seed |
Co-Investors
b2venture
1 deal together
Geberit
1 deal together
Intermountain Healthcare
1 deal together
Ornament Health
1 deal together
Safeguard Scientifics
1 deal together
About POCARED Diagnostics
POCARED DiagnosticsTM is an in-vitro diagnostics company developing a next generation microbiology platform. POCAREDTM is revolutionizing infectious disease diagnosis with CULTURE-FREE MicrobiologyTM POCARED’sTM P-1000TM; a platform that is fully automated, reagent free, real time, and easy to operate. POCARED'TM saves several critical days inresult reporting by providing multi-source detection, quantification and species identification results for bacteria and yeast in few minutes, directly from the specimen.
POCARED Diagnostics Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Edward Ludwig
Non-Executive Chairman of the Board of Directors
|
|||
|
Gal Ingber
Co-Founder , VP R&D
|
|||
|
Jonathan Gurfinkel
Co-Founder, President and CEO
|
|||
|
Zvika Blutstein
COO
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Edward Ludwig invest in?
Edward Ludwig invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Edward Ludwig last invest?
The most recent investment recorded for Edward Ludwig closed in Apr 2021. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
